314 results on '"Lee, Yoon-Se"'
Search Results
102. Knockdown of β-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines
- Author
-
Chang, Hyo Won, primary, Lee, Yoon Se, additional, Nam, Hae Yun, additional, Han, Myoung Wol, additional, Kim, Hyo Jung, additional, Moon, So Young, additional, Jeon, Hyesung, additional, Park, Jung Je, additional, Carey, Thomas E., additional, Chang, Sung Eun, additional, Kim, Seong Who, additional, and Kim, Sang Yoon, additional
- Published
- 2013
- Full Text
- View/download PDF
103. Isolation of Mesenchymal Stromal Cells (MSCs) from Human Adenoid Tissue
- Author
-
Lee, Yoon Se, primary, Lee, Jae-Eun, additional, Park, Hee-Young, additional, Lim, Yun-Sung, additional, Lee, Jin-Choon, additional, Wang, Soo-Geun, additional, and Lee, Byung-Joo, additional
- Published
- 2013
- Full Text
- View/download PDF
104. The Relationship between the Number of Preserved Parathyroid Glands and Clinical Aspects after Total Thyroidectomy and Central Lymph Node Dissection in Papillary Thyroid Carcinoma
- Author
-
Wie, Chan-Eun, primary, Wang, Soo-Geun, additional, Lee, Byung-Joo, additional, Lim, Yun-Sung, additional, Lee, Yoon-Se, additional, Kim, In-Ju, additional, Kim, Bo-Hyun, additional, Kim, Sang-Soo, additional, Cheon, Yong-Il, additional, and Lee, Jin-Choon, additional
- Published
- 2013
- Full Text
- View/download PDF
105. Laryngeal Pseudotumor Arising in the Paraglottic Space
- Author
-
Lee, Sang Min, primary, Goh, Jin-Young, additional, Wang, Soo-Geun, additional, and Lee, Yoon Se, additional
- Published
- 2012
- Full Text
- View/download PDF
106. Frozen biopsy of central compartment in papillary thyroid cancer: Quantitative nodal analysis
- Author
-
Lim, Yun-Sung, primary, Choi, Sung-Won, additional, Lee, Yoon Se, additional, Lee, Jin-Choon, additional, Lee, Byung-Joo, additional, Wang, Soo-Geun, additional, Son, Seok-Man, additional, Kim, In-Ju, additional, and Shin, Dong-Hoon, additional
- Published
- 2012
- Full Text
- View/download PDF
107. Sclerosing sweat duct carcinoma of the nose with multiple cervical lymph node metastasis
- Author
-
Moon, Mi-Jin, primary, Cho, Kyu-Sup, additional, Lee, Yoon-Se, additional, and Nam, Su-Bong, additional
- Published
- 2012
- Full Text
- View/download PDF
108. CLN Metastasis with Papillary Thyroid Cancer in the Isthmus
- Author
-
Lee, Jin‐Choon, primary, Lee, Byung‐Joo, additional, Wang, Soo‐Geun, additional, Lim, Yun‐Sung, additional, and Lee, Yoon‐Se, additional
- Published
- 2012
- Full Text
- View/download PDF
109. Can the Palatine Tonsil be a Source of Mesenchymal Stem Cells with Immunomodulatory Property?
- Author
-
Lee, Yoon Se, primary, Park, Hee-Young, additional, Lim, Yun Sung, additional, Lee, Jin-Choon, additional, Wang, Soo-Geun, additional, Jung, Jin Sup, additional, and Lee, Byung-Joo, additional
- Published
- 2012
- Full Text
- View/download PDF
110. Clinical Applications of Botulinum Toxin Type A for the Laryngologic Disorders
- Author
-
Jang, Min-Ji, primary, Lee, Yoon Se, additional, Wang, Soo-Geun, additional, and Lee, Byung-Joo, additional
- Published
- 2012
- Full Text
- View/download PDF
111. Clinical Applications of Mesenchymal Stem Cells in the Otolaryngology Fields
- Author
-
Whang, Bong-Woon, primary, Lee, Yoon Se, additional, and Lee, Byung-Joo, additional
- Published
- 2012
- Full Text
- View/download PDF
112. A Case of Synovial Sarcoma Involved in the Infratemporal Fossa Resected with Subtemporal-Infratemporal Fossa Approach with Hearing Preservation
- Author
-
Shin, Seung-Kuk, primary, Woo, Chang-Ki, additional, Nam, Soo-Bong, additional, and Lee, Yoon-Se, additional
- Published
- 2012
- Full Text
- View/download PDF
113. Growth Inhibitory Effect of Palatine Tonsil-derived Mesenchymal Stem Cells on Head and Neck Squamous Cell Carcinoma Cells
- Author
-
Lim, Yun-Sung, primary, Lee, Jin-Choon, additional, Lee, Yoon Se, additional, Lee, Byung-Joo, additional, and Wang, Soo-Geun, additional
- Published
- 2012
- Full Text
- View/download PDF
114. Multidisciplinary Approach to an Arteriovenous Malformation
- Author
-
Wang, Soo‐Geun, primary, Kim, Jeong Tae, additional, Nam, Soo Bong, additional, Lee, Yoon Se, additional, and Lim, Yun Sung, additional
- Published
- 2011
- Full Text
- View/download PDF
115. Quantitative Frozen Biopsy of Central Metastasis in PTC
- Author
-
Lim, Yun‐Sung, primary, Lee, Yoon Se, additional, Lee, Byung‐Joo, additional, Lee, Jin‐Choon, additional, and Wang, Soo‐Geun, additional
- Published
- 2011
- Full Text
- View/download PDF
116. A Case of Spontaneous Massive Pharyngeal Bleeding Caused by Anterior Cervical Osteophytes
- Author
-
Choi, Sung Won, primary, Wang, Soo-Geun, additional, Lee, Jin-Choon, additional, and Lee, Yoon Se, additional
- Published
- 2011
- Full Text
- View/download PDF
117. Conservative Managements of Failed Free Flap Reconstruction in Head and Neck Cancer : Reports of 2 Cases and Literature Reviews
- Author
-
Lee, Yoon Se, primary, Choi, Sung Won, additional, Lim, Yune Sung, additional, and Wang, Soo-Geun, additional
- Published
- 2010
- Full Text
- View/download PDF
118. Clinical Features and Managements of Presbyphonia
- Author
-
Lim, Yune-Sung, primary, Lee, Yoon-Se, additional, and Lee, Jong-Kil, additional
- Published
- 2010
- Full Text
- View/download PDF
119. Role of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Preoperative Staging of Early Glottic Cancer
- Author
-
Song, Chan Il, primary, Han, Myung Woul, additional, Lee, Yoon Se, additional, Kim, Sang Yoon, additional, Choi, Seung-Ho, additional, and Nam, Soon Yuhl, additional
- Published
- 2010
- Full Text
- View/download PDF
120. SP210 – Frequency & pattern of cervical lymph node skip metastasis
- Author
-
Wang, Soo Guen, primary, Shin, Sugn-Chan, additional, Lim, Yun Sung, additional, Lee, Yoon Se, additional, Lee, Jin Choon, additional, and Lee, Byung Joo, additional
- Published
- 2009
- Full Text
- View/download PDF
121. SP200 – Frequency and pattern of cervical lymph node skip metastasis
- Author
-
Shin, Sugn-Chan, primary, Lim, Yun Sung, additional, Lee, Yoon Se, additional, Lee, Jin Choon, additional, Lee, Byung Joo, additional, and Wang, Soo Geun, additional
- Published
- 2009
- Full Text
- View/download PDF
122. Clinical Analysis of Carcinoma Ex Pleomorphic Adenoma
- Author
-
Lee, Yoon Se, primary, Hyun, Sang Min, additional, Lim, Gil Chai, additional, Choi, Seung-Ho, additional, Kim, Sang Yoon, additional, and Nam, Soon Yuhl, additional
- Published
- 2009
- Full Text
- View/download PDF
123. Diagnosis of LPRD
- Author
-
Lee, Yoon-Se, primary and Lee, Jin-Choon, additional
- Published
- 2009
- Full Text
- View/download PDF
124. Clinical Outcome of Salvage Treatment for Recurrent Supraglottic Cancer
- Author
-
Kim, Ji Heui, primary, Lee, Yoon Se, additional, Kwon, Min Su, additional, Roh, Jong-Lyel, additional, Choi, Seung-Ho, additional, Kim, Sang Yoon, additional, and Nam, Soon Yuhl, additional
- Published
- 2009
- Full Text
- View/download PDF
125. Intracordal auricular cartilage injection for unilateral vocal fold paralysis.
- Author
-
Lim, Yun-Sung, Lee, Yoon Se, Lee, Jin-Choon, Lee, Byung-Joo, Wang, Soo-Geun, Park, Hee-June, Nam, Su-Bong, and Bae, Yong-Chan
- Abstract
We evaluated the efficacy and outcome of intracordal auricular cartilage injection in patients with unilateral vocal fold paralysis. Our interest developed from findings of a canine model study that reported that histologic characteristics of cartilage were preserved 2 and 3 years after intracordal autologous cartilage injection. Between May 2002 and July 2010, 29 patients with breathy dysphonia caused by unilateral vocal fold paralysis underwent intracordal auricular cartilage injection. Each subject underwent preoperative and postoperative perceptual assessments, acoustical voice analysis, and videostroboscopy. Fourteen patients were male, and the mean age was 52-years old. Patients were tracked for a mean duration of 257 days. Injections were performed through a transoral approach under general anesthesia. Perceptual assessments by GRBAS scale, acoustic parameters of jitter, shimmer, noise-to-harmonic ratio, and maximum phonation time significantly improved at 3, 6, and 12 months after cartilage injection ( p < 0.005). No major complications were observed after injection. Initial clinical results with intracordal auricular cartilage injection are promising for patients with unilateral vocal fold paralysis. Autologous auricular cartilage can be a safe, effective, and alternative material for vocal fold medialization, and can be a long lasting one. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 47-51, 2015. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
126. PP169: Negative prognostic implication of fibrotic pattern in papillary thyroid cancer
- Author
-
Lee, Yoon Se, Lim, Yun-Sung, Woo, Chang-Gi, Lee, Jin-Choon, Wang, Soo-Geun, and Lee, Byung-Joo
- Published
- 2013
- Full Text
- View/download PDF
127. PP049: Growth pattern of micropapillary thyroid cancer without extrathyroidal extension predicts central lymph node metastasis
- Author
-
Lee, Yoon Se, Lim, Yun-Sung, Woo, Chang-Gi, Lee, Jin-Choon, Wang, Soo-Geun, Lee, Kang Dae, and Lee, Byung-Joo
- Published
- 2013
- Full Text
- View/download PDF
128. Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial.
- Author
-
Kim, Su Il, Lee, Young Chan, Cha, Wonjae, Jung, Ah Ra, Jang, Jeon Yeob, Choi, Jeong-Seok, Lee, Dong Kun, Lee, Hwan Ho, Kwon, Min Su, Lee, Yoon Se, and Eun, Young-Gyu
- Subjects
- *
GASTRIC acid , *PROTON pump inhibitors , *CLINICAL trials , *SYMPTOMS , *ESOMEPRAZOLE - Abstract
Purpose: Laryngopharyngeal reflux disease (LPRD) is mainly treated with proton pump inhibitors (PPI) such as esomeprazole, which have shortcomings like delayed absorption and increased osteoporosis. Fexuprazan is a novel potent potassium-competitive acid blocker that inhibits gastric acid secretion with rapid onset and long duration of action. To assess the efficacy and safety of fexuprazan compared to esomeprazole in patients with LPRD.This prospective, randomized, double-blinded, multicenter, active-controlled trial was conducted in nine otolaryngologic clinics
. Patients with reflux symptom index (RSI) ≥ 13 and reflux finding score (RFS) ≥ 7 were randomly assigned to the fexuprazan or esomeprazole groups, and received fexuprazan 40-mg or esomeprazole 40-mg once daily for 8 weeks. The outcomes were (1) mean change, change rate, and valid rate in RSI, RFS, and LPR-related questionnaires; and (2) adverse events.A total of 136 patients (fexuprazann = 68, esomeprazolen = 68) were followed up for ≥ 1 month. Each parameter significantly improved after 4 and 8 weeks in each group, with no significant differences between the two groups. For those with severe symptoms (RSI ≥ 18), the fexuprazan group (n = 32) showed more improvement in the mean change and change rate in the RSI than esomeprazole group (n = 31) after 4 weeks (p = .036 and .045, respectively). This phenomenon was especially observed in hoarseness and troublesome cough.Fexuprazan improved symptoms and signs without no serious adverse events in patients with LPRD. In patients with severe symptoms, fexuprazan resulted in a faster symptom improvement than PPI.KCT0007251, https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22100.Methods: Laryngopharyngeal reflux disease (LPRD) is mainly treated with proton pump inhibitors (PPI) such as esomeprazole, which have shortcomings like delayed absorption and increased osteoporosis. Fexuprazan is a novel potent potassium-competitive acid blocker that inhibits gastric acid secretion with rapid onset and long duration of action. To assess the efficacy and safety of fexuprazan compared to esomeprazole in patients with LPRD.This prospective, randomized, double-blinded, multicenter, active-controlled trial was conducted in nine otolaryngologic clinics. Patients with reflux symptom index (RSI) ≥ 13 and reflux finding score (RFS) ≥ 7 were randomly assigned to the fexuprazan or esomeprazole groups, and received fexuprazan 40-mg or esomeprazole 40-mg once daily for 8 weeks. The outcomes were (1) mean change, change rate, and valid rate in RSI, RFS, and LPR-related questionnaires; and (2) adverse events.A total of 136 patients (fexuprazann = 68, esomeprazolen = 68) were followed up for ≥ 1 month. Each parameter significantly improved after 4 and 8 weeks in each group, with no significant differences between the two groups. For those with severe symptoms (RSI ≥ 18), the fexuprazan group (n = 32) showed more improvement in the mean change and change rate in the RSI than esomeprazole group (n = 31) after 4 weeks (p = .036 and .045, respectively). This phenomenon was especially observed in hoarseness and troublesome cough.Fexuprazan improved symptoms and signs without no serious adverse events in patients with LPRD. In patients with severe symptoms, fexuprazan resulted in a faster symptom improvement than PPI.KCT0007251, https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22100.Results: Laryngopharyngeal reflux disease (LPRD) is mainly treated with proton pump inhibitors (PPI) such as esomeprazole, which have shortcomings like delayed absorption and increased osteoporosis. Fexuprazan is a novel potent potassium-competitive acid blocker that inhibits gastric acid secretion with rapid onset and long duration of action. To assess the efficacy and safety of fexuprazan compared to esomeprazole in patients with LPRD.This prospective, randomized, double-blinded, multicenter, active-controlled trial was conducted in nine otolaryngologic clinics. Patients with reflux symptom index (RSI) ≥ 13 and reflux finding score (RFS) ≥ 7 were randomly assigned to the fexuprazan or esomeprazole groups, and received fexuprazan 40-mg or esomeprazole 40-mg once daily for 8 weeks. The outcomes were (1) mean change, change rate, and valid rate in RSI, RFS, and LPR-related questionnaires; and (2) adverse events.A total of 136 patients (fexuprazann = 68, esomeprazolen = 68) were followed up for ≥ 1 month. Each parameter significantly improved after 4 and 8 weeks in each group, with no significant differences between the two groups. For those with severe symptoms (RSI ≥ 18), the fexuprazan group (n = 32) showed more improvement in the mean change and change rate in the RSI than esomeprazole group (n = 31) after 4 weeks (p = .036 and .045, respectively). This phenomenon was especially observed in hoarseness and troublesome cough.Fexuprazan improved symptoms and signs without no serious adverse events in patients with LPRD. In patients with severe symptoms, fexuprazan resulted in a faster symptom improvement than PPI.KCT0007251, https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22100.Conclusion: Laryngopharyngeal reflux disease (LPRD) is mainly treated with proton pump inhibitors (PPI) such as esomeprazole, which have shortcomings like delayed absorption and increased osteoporosis. Fexuprazan is a novel potent potassium-competitive acid blocker that inhibits gastric acid secretion with rapid onset and long duration of action. To assess the efficacy and safety of fexuprazan compared to esomeprazole in patients with LPRD.This prospective, randomized, double-blinded, multicenter, active-controlled trial was conducted in nine otolaryngologic clinics. Patients with reflux symptom index (RSI) ≥ 13 and reflux finding score (RFS) ≥ 7 were randomly assigned to the fexuprazan or esomeprazole groups, and received fexuprazan 40-mg or esomeprazole 40-mg once daily for 8 weeks. The outcomes were (1) mean change, change rate, and valid rate in RSI, RFS, and LPR-related questionnaires; and (2) adverse events.A total of 136 patients (fexuprazann = 68, esomeprazolen = 68) were followed up for ≥ 1 month. Each parameter significantly improved after 4 and 8 weeks in each group, with no significant differences between the two groups. For those with severe symptoms (RSI ≥ 18), the fexuprazan group (n = 32) showed more improvement in the mean change and change rate in the RSI than esomeprazole group (n = 31) after 4 weeks (p = .036 and .045, respectively). This phenomenon was especially observed in hoarseness and troublesome cough.Fexuprazan improved symptoms and signs without no serious adverse events in patients with LPRD. In patients with severe symptoms, fexuprazan resulted in a faster symptom improvement than PPI.KCT0007251, https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22100.Trial registration: Laryngopharyngeal reflux disease (LPRD) is mainly treated with proton pump inhibitors (PPI) such as esomeprazole, which have shortcomings like delayed absorption and increased osteoporosis. Fexuprazan is a novel potent potassium-competitive acid blocker that inhibits gastric acid secretion with rapid onset and long duration of action. To assess the efficacy and safety of fexuprazan compared to esomeprazole in patients with LPRD.This prospective, randomized, double-blinded, multicenter, active-controlled trial was conducted in nine otolaryngologic clinics. Patients with reflux symptom index (RSI) ≥ 13 and reflux finding score (RFS) ≥ 7 were randomly assigned to the fexuprazan or esomeprazole groups, and received fexuprazan 40-mg or esomeprazole 40-mg once daily for 8 weeks. The outcomes were (1) mean change, change rate, and valid rate in RSI, RFS, and LPR-related questionnaires; and (2) adverse events.A total of 136 patients (fexuprazann = 68, esomeprazolen = 68) were followed up for ≥ 1 month. Each parameter significantly improved after 4 and 8 weeks in each group, with no significant differences between the two groups. For those with severe symptoms (RSI ≥ 18), the fexuprazan group (n = 32) showed more improvement in the mean change and change rate in the RSI than esomeprazole group (n = 31) after 4 weeks (p = .036 and .045, respectively). This phenomenon was especially observed in hoarseness and troublesome cough.Fexuprazan improved symptoms and signs without no serious adverse events in patients with LPRD. In patients with severe symptoms, fexuprazan resulted in a faster symptom improvement than PPI.KCT0007251, https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22100. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
129. Feedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG.
- Author
-
Lee, Jong Cheol, Kim, Gui Chul, Lee, Na Kyeong, Kim, Seong Who, Cho, Young Seok, Chung, Seung Woo, Lee, Yoon Se, Chang, Hyo Won, Byun, Youngro, and Kim, Sang Yoon
- Subjects
- *
TUMOR growth , *CANCER cells , *ANTINEOPLASTIC agents , *CANCER relapse , *CANCER treatment , *EXONUCLEASES - Abstract
Therapy-induced senescence (TIS), a common outcome of current cancer therapy, is a known cause of late recurrence and metastasis and thus its eradication is crucial for therapy success. In this study, we introduced a conceptually novel strategy combining radiation-induced apoptosis-targeted chemotherapy (RIATC) with an effective glycolysis inhibitor, 2-deoxy- d -glucose (2DG) to target TIS. RIATC releases cytotoxic payload by amplification, continually increasing TIS, and this can be targeted by 2DG that stimulates an intrinsic apoptotic pathway in senescent cells, the senolysis; the senolytic 2DG also sensitizes cancer cells to chemo/radiation treatment. Anti-tumor efficacy of RIATC was investigated in numerous tumor models, and various cancer types were screened for TIS. Furthermore, in vitro evaluations of molecular markers of senescence, such as senescence-associated β-galactosidase (SA-β-Gal) assay, were performed to confirm that TIS was induced by RIATC therapy in MCF-7 cells. The combination therapy with 2DG proved to be effective in MCF-7 tumor-bearing mice that demonstrated feedback amplification of senolysis and successful inhibition of tumor growth. Our findings suggest that RIATC, when given together with 2DG, can overcome therapy-induced senescence and this combination is a promising strategy that enhances the therapeutic benefit of anti-cancer cytotoxic therapy. 2DG (2-deoxy-D-glycose) and radiation-induced apoptosis-targeted chemotherapy (RIATC) triggers a feedback amplification of senolysis, resulting in augmented apoptosis from a small fraction of therapy-induced senescent (TIS) cancer cells. [Display omitted] • Radiation-induced apoptosis-targeted chemotherapy (RIATC). • Peptide-doxorubicin conjugate with enhanced half-life and targeted activation. • 2DG induces the apoptosis of TIS cancer cells, senolysis. • 2DG and RIATC synergistically trigger the feedback amplification of senolysis, augmented apoptosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
130. Albumin metabolism targeted peptide-drug conjugate strategy for targeting pan-KRAS mutant cancer.
- Author
-
Cho, Young Seok, Kim, Gui Chul, Lee, Hye Min, Kim, Byoungmo, Kim, Ha Rin, Chung, Seung Woo, Chang, Hyo Won, Ko, Yoon Gun, Lee, Yoon Se, Kim, Seong Who, Byun, Youngro, and Kim, Sang Yoon
- Subjects
- *
RADIATION-induced bystander effect , *RAS oncogenes , *METABOLISM , *CANCER cells , *ANTINEOPLASTIC agents - Abstract
Despite recent breakthroughs in the development of direct KRAS inhibitors and modulators, no drugs targeting pan-KRAS mutant cancers are clinically available. Here, we report a novel strategy to treat pan-KRAS cancers using a caspase-3 cleavable peptide–drug conjugate that exploits enhanced albumin metabolism in KRAS altered cancers to deliver a cytotoxic agent that can induce a widespread bystander killing effect in tumor cells. Increased albumin metabolism in KRAS mutant cancer cells induced apoptosis via the intracellular uptake of albumin-bound MPD1. This allowed caspase-3 upregulation activated MPD1 to release the payload and exert the non-selective killing of neighboring cancer cells. MPD1 exhibited potent and durable antitumor efficacy in mouse xenograft models with different KRAS genotypes. An augmentation of anti-cancer efficacy was achieved by the bystander killing effect derived from the caspase-3 mediated activation of MPD1. In summary, albumin metabolism-induced apoptosis, together with the bystander killing effect of MPD1 boosted by caspase-3 mediated activation, intensified the efficacy of MPD1 in KRAS mutant cancers. These findings suggest that this novel peptide-drug conjugate could be a promising breakthrough for the treatment in the targeting of pan-KRAS mutant cancers. [Display omitted] • KRAS mutant cancer cells have upregulated albumin metabolism level. • Enhanced intracellular delivery of albumin-binding peptide-doxorubicin conjugate. • Albumin metabolism-induced cancer cell apoptosis. • Bystander killing of cancer cells by caspase-3 mediated activation of peptide-drug conjugate. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
131. Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma.
- Author
-
Kwon, Minsu, Nam, Gi-Hoon, Jung, Hanul, Kim, Seong A, Kim, Seohyun, Choi, Yeonju, Lee, Yoon Se, Cho, Hyo Jung, and Kim, In-San
- Subjects
- *
CISPLATIN , *SQUAMOUS cell carcinoma , *IMMUNOTHERAPY , *ANTINEOPLASTIC agents , *ANTINEOPLASTIC combined chemotherapy protocols , *OTOTOXICITY - Abstract
The purpose of this study was to determine whether statins can enhance anticancer effects in head and neck squamous cell carcinoma (HNSCC) when used with cisplatin and act as immunogenic cell death (ICD) inducers that can be used in cancer immunotherapy. Statins alone showed both in vitro and in vivo inhibitory effects against HNSCC, and synergistic antitumor effects were observed when combined with cisplatin in a syngeneic murine HNSCC model. Statins increased calreticulin exposure and endoplasmic reticulum stress-related signals in HNSCC cells. In addition, it was confirmed that statins could activate antigen-presenting cells and tumor-specific CD8+ T cells with an increase in their numbers in the tumor tissues and draining lymph nodes, with this effect showing significant improvement following the combination therapy with cisplatin. Moreover, in triple combination with both cisplatin and anti-programmed cell death 1 receptor (anti-PD-1) antibody, statins dramatically induced further tumor eradication and improved the survival of tumor-bearing mice. Taken together, these results demonstrate that statins, administered in combination with anti-PD-1 antibody, could enhance the anticancer effect of cisplatin and potentiate the efficacy of immunotherapy for HNSCC and present a rationale for repurposing statins as an adjuvant immunotherapeutic option for HNSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
132. Prediction model for cervical lymph node metastasis in human papillomavirus-related oropharyngeal squamous cell carcinomas.
- Author
-
Joo, Leehi, Bae, Yun Jung, Choi, Young Jun, Lee, Yoon Se, Chung, Sae Rom, Suh, Chong Hyun, Kim, Seon-Ok, Baek, Jung Hwan, and Lee, Jeong Hyun
- Abstract
Objectives: To develop and validate a risk scoring system based on clinical and imaging findings to predict lymph node metastasis from HPV-related oropharyngeal squamous cell carcinomas. Methods: This study population who had undergone neck dissections or lymph node biopsies in patients with HPV+ OPSCC was obtained from a historical cohort from two tertiary referral hospitals. The training set from one hospital included 455 lymph nodes from 82 patients, and the test set from the other hospital included 150 lymph nodes from 42 patients. The baseline clinical and imaging findings on pretreatment CT or MR were investigated and the reference standards were the histopathologic results. A risk scoring system was constructed based on logistic regression and validated both internally and externally. Results: A 7-point risk scoring system was developed based on the following variables: central necrosis, infiltration of adjacent planes, lymph node level, and the maximal axial diameter of the lymph node. This risk scoring system showed good discriminative ability for metastasis in the training set (C-statistic 0.952; 95% CI, 0.931–0.972) and test set (C-statistic 0.968, 95% CI, 0.936–0.999) and good calibration ability in the training set (p = 0.723) and test set (p = 0.253). Conclusions: We developed and validated a reliable risk scoring system that predicts lymph node metastasis from HPV+ OPSCCs based on the clinical data and pretreatment imaging findings. We expect this risk scoring system to be a useful guide for better decision-making in practice. Key Points: • It is important to diagnose lymph node metastasis from HPV+ OPSCC for treatment planning; however, there has been little research on that. • We developed and externally validated a new scoring system for stratifying the risk of lymph node metastasis from HPV+ OPSCC based on clinical and imaging data. • A predictive model combining both clinical and imaging data showed high diagnostic accuracy and efficiency for lymph node metastasis from HPV+ OPSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
133. Enhancer of zeste homolog 2 (EZH2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells.
- Author
-
Chang, Hyo Won, Park, Jung Je, Lee, Won Hyeok, Kim, Song Hee, Lee, Jong Cheol, Nam, Hae Yun, Kim, Mi Ra, Han, Myung Woul, Lee, Yoon Se, Kim, Sang Yoon, and Kim, Seong Who
- Subjects
- *
HEAD & neck cancer , *CANCER cells , *GLUCOSE , *P53 antioncogene , *STARVATION , *CELL analysis - Abstract
Sirtuin 3 (SIRT3) regulates mitochondrial function as a mitochondrial deacetylase during oxidative stress. However, the specific regulatory mechanism and function of SIRT3 in radioresistant cancer cells are unclear. In this study, we aim to investigate how SIRT3 determines the susceptibility to glucose deprivation and its regulation in p53-based radioresistant head and neck cancer cells. We observed mitochondrial function using two established isogenic radioresistant subclones (HN3R-A [p53 null] and HN3R-B [p53 R282W]) with intratumoral p53 heterogeneity. Cell counting analysis was performed to evaluate cell proliferation and cell death. The correlation between the regulation of SIRT3 and enhancer of zeste homolog 2 (EZH2) was confirmed by immunoblotting and chromatin immunoprecipitation assay. p53-deficient radioresistant cells (HN3R-A) expression reduced SIRT3 levels and increased sensitivity to glucose deprivation due to mitochondrial dysfunction compared to other cells. In these cells, activation of SIRT3 significantly prevented glucose deprivation-induced cell death, whereas the loss of SIRT3 increased the susceptibility to glucose deficiency. We discovered that radiation-induced EZH2 directly binds to the SIRT3 promoter and represses the expression. Conversely, inhibiting EZH2 increased the expression of SIRT3 through epigenetic changes. Our findings indicate that p53-deficient radioresistant cells with enhanced EZH2 exhibit increased sensitivity to glucose deprivation due to SIRT3 suppression. The regulation of SIRT3 by EZH2 plays a critical role in determining the cell response to glucose deficiency in radioresistant cancer cells. Therefore, EZH2-dependent SIRT3 could be used as a predictive biomarker to select treatment options for patients with radiation-resistance. • p53-deficient radioresistant cells are sensitive to glucose starvation. • SIRT3 is a pivotal regulator of glucose deprivation-induced cell death. • EZH2 directly binds to the SIRT3 promoter and represses the expression of SIRT3. • EZH2-dependent SIRT3: a predictive biomarker for radiation-resistant patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
134. Metastatic lymph node burden predictive of survival in patients undergoing primary surgery for laryngeal and hypopharyngeal cancer.
- Author
-
Choi, Yeonjoo, Bin-Manie, Manal, Roh, Jong-Lyel, Cho, Kyung-Ja, Lee, Yoon Se, Choi, Seung-Ho, Nam, Soon Yuhl, and Kim, Sang Yoon
- Subjects
- *
HYPOPHARYNGEAL cancer , *LARYNGEAL cancer , *LYMPH nodes , *RECURSIVE partitioning , *LARYNGECTOMY - Abstract
Purpose: Metastatic lymph node (LN) burden is one of the most important prognosticators in human solid cancers, but has rarely been examined in laryngeal and hypopharyngeal cancers (LHC). We evaluated the nodal factors predictive of recurrence and survival in patients with LHC. Methods: This study included 141 consecutive patients who underwent primary surgery and neck dissection for previously untreated LHC at our tertiary referral centre. Nodal factors included the presence of pathological LN metastasis, number of positive LNs, LN ratio, and extra-nodal extension (ENE). Our proposed N classification was analysed by recursive partitioning analysis and compared with the AJCC and other N classifications using the c-index. Univariate and multivariate Cox proportional hazard regression analyses were used to define significant predictors of post-treatment disease-free survival (DFS) and overall survival (OS). Results: Of the 141 patients, 66 (46.8%) had positive LNs, and 27 (19.1%) had ENE. In multivariate analyses, the number of positive LNs was strongly associated with DFS and OS outcomes (P < 0.01). Our new N classification was proposed with four categories, such as N0 (0 LN +), N1 (1 LN +), N2 (2–4 LN + or ENE) and N3 (≥ 5 LN +). The C-index of our new N classification improved the OS prediction (0.718) compared with the AJCC and the other N classifications (0.704–0.713). Conclusion: Metastatic LN burden is an important predictor of survival in patients with LHC. A proposed N classification using the number of positive LNs and ENE might improve the LHC survival prediction. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
135. The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.
- Author
-
Hwang, Hee Sang, Park, Chan-Sik, Huh, Jooryung, Yoon, Dok Hyun, Hong, Jung Yong, Suh, Cheolwon, Lee, Yoon Se, Ko, Young Hyeh, Kim, Seok Jin, and Kim, Won Seog
- Abstract
Cell-of-origin (COO) classification of diffuse large B cell lymphoma (DLBCL) is increasingly important due to its prognostic significance and the development of subtype-specific therapeutics. We compared the clinical utility of the Lymph2Cx assay against four widely used immunohistochemical algorithms in 150 R-CHOP-treated DLBCL patients using archival tissue. In contrast to the predominance of germinal center B cell-like (GCB) subtype in Western populations, Lymph2Cx assay classified more than half of the Korean cases as the activated B cell-like (ABC) subtype (ABC, 83/150 [55.3%]; GCB, 51/150 [34.0%]; unclassifiable, 16/150 [10.7%]). Predominance of ABC subtype tended to be more pronounced in the nodal lymphomas than in the extranodal lymphomas. However, among the primary extranodal sites, ABC subgroups predominated in primary testicular, breast, and adrenal gland lymphomas. The classification of COO by Lymph2Cx assay did not show any significant association with clinical parameters. The overall concordance rates of the immunohistochemical algorithms with the Lymph2Cx ranged from 78.0 to 84.3%. However, 47.1-66.7% of the cases of the Lymph2Cx-defined GCB subgroup were misclassified as the non-GCB class by the IHC algorithms. The survival of Lymph2Cx-classified COO subtypes was not significantly different in the present cohort. In conclusion, ABC subtype predominated over GCB in Korean patients. There are significant discrepancies between the immunohistochemistry and Lymph2Cx classifications, especially in GCB subtype. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
136. Discrete prognostic implication of sarcopenia according to nutritional status in surgically treated patients with hypopharyngeal cancer.
- Author
-
Go JY, Lee YS, Choi YJ, Kim MJ, Kwon MS, Jung YH, Choi SH, and Nam SY
- Subjects
- Humans, Male, Female, Prognosis, Middle Aged, Aged, Retrospective Studies, Nutrition Assessment, Carcinoma, Squamous Cell surgery, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell complications, Carcinoma, Squamous Cell pathology, Survival Rate, Adult, Sarcopenia complications, Hypopharyngeal Neoplasms surgery, Hypopharyngeal Neoplasms mortality, Hypopharyngeal Neoplasms complications, Hypopharyngeal Neoplasms pathology, Nutritional Status
- Abstract
Background: Nutritional status and sarcopenia affects the prognosis of head and neck cancers including hypopharyngeal cancer. Hypopharyngeal cancer patients tend to exhibit sarcopenia, which is associated with poor treatment outcomes. This study aims to determine the correlation between nutritional status and sarcopenia, and their prognostic role in surgically treated hypopharyngeal cancer., Materials and Methods: Patients who had been diagnosed with squamous cell carcinoma originating from the hypopharynx and underwent surgery between January 2009 and December 2019 were enrolled in this study. The median neutrophil-to-lymphocyte ratio and prognostic nutritional index (PNI) of the cohort were considered the cut-off values. Sarcopenia was evaluated by measuring skeletal muscle index (SMI) at the third lumbar vertebra. Clinical and serological factors predictive of survival outcomes were evaluated., Results: Patients with high PNI showed better 5-year Overall survival (OS) (52.8% vs. 27.2%, p = 0.001) and disease-free survival (DFS) (59.6% vs. 44.6%, p = 0.033) than those with low PNI. Likewise, patients with low SMI showed worse 5-year OS (25.0% vs. 60.9%, p = 0.002) and DFS (42.4% vs. 68.7%, p = 0.034) than patients with high SMI. Among the patients with high PNI, those with sarcopenia displayed significantly worse OS than those with high SMI (78.0% vs. 34.4%, p = 0.049). High PNI with high SMI presented better overall (p = 0.010) and DFS (p = 0.055) than any other group., Conclusions: Both sarcopenia and PNI were associated with the prognosis of hypopharyngeal cancer. Considering that PNI and sarcopenia indicate the nutritional status, nutritional status may be a significant risk factor. Therefore, nutritional support that ameliorates sarcopenia may improve survival outcomes in surgically treated patients with hypopharyngeal cancer., (© 2024 The Author(s). World Journal of Surgery published by John Wiley & Sons Ltd on behalf of International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC).)
- Published
- 2024
- Full Text
- View/download PDF
137. Management for recurrent laryngeal nerve paralysis following oesophagectomy for oesophageal cancer: thoracic surgeon perspective.
- Author
-
Lee JO, Yun JK, Jeong YH, Lee YS, and Kim YH
- Abstract
Background: Recurrent laryngeal nerve (RLN) paralysis following oesophagectomy may increase postoperative morbidity and mortality. However, clinical studies on this complication are uncommon. The aim of this study was to report the clinical course of patients with RLN paralysis following oesophageal cancer surgery., Methods: We retrospectively examined patients who underwent oesophagectomy for oesophageal carcinoma at Asan Medical Center between January 2013 and November 2018. We enrolled 189 patients with RLN paralysis confirmed using laryngoscopy in this study., Results: Of the 189 patients, 22 patients had bilateral RLN paralysis, and 167 patients had unilateral RLN paralysis. Every patient received oral feeding rehabilitation, and 145 (76.7%) patients received hyaluronic acid injection laryngoplasty. During the postoperative period, 21 (11.1%) patients experienced aspiration pneumonia and recovered. One patient died of severe pulmonary complication. Twenty-four (12.7%) patients underwent feeding jejunotomy, while 11 (5.9%) patients underwent tracheostomy. In total, 173 (91.5%) patients were discharged with oral nutrition, and the median time to begin oral diet was 9 days. Statistical analysis using logistic regression revealed that only the advanced T stage affected nerve recovery. More than 50% of the patients showed nerve recovery within 6 months, and 165 (87.9%) patients fully or partially recovered during the observation period., Conclusions: RLN paralysis following oesophagectomy in oesophageal carcinoma is a predictable complication. In patients with RLN paralysis, early detection and intervention through multidisciplinary cooperation are required, and the incidence of postoperative complications can be reduced by implementing the appropriate management., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-9/coif). The authors have no conflicts of interest to declare., (2024 Journal of Thoracic Disease. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
138. Ethanol Ablation of Ranulas and Risk Factor Analysis for Recurrence.
- Author
-
Suh PS, Lee JH, Roh YH, Moon HH, Chung SR, Kwon MS, Choi YJ, Lee YS, Baek JH, and Choi SH
- Subjects
- Humans, Female, Male, Risk Factors, Ablation Techniques methods, Adolescent, Adult, Child, Retrospective Studies, Treatment Outcome, Middle Aged, Young Adult, Recurrence, Ranula surgery, Ethanol therapeutic use
- Abstract
Importance: Ethanol ablation (EA) was shown to be safe and effective for treating ranula, but few studies have assessed long-term outcomes and recurrence of ranula after EA., Objective: To evaluate the long-term outcomes and the risk factors for recurrence and receipt of subsequent surgery in patients who underwent treatment with EA for ranula., Design, Setting, and Participants: This case-series study was conducted at a single tertiary hospital and assessed patients who were treated with EA between July 2009 and March 2021. Among 70 consecutive patients, those with follow-up loss or who were followed up for less than 24 months were excluded., Exposures: EA for ranula., Main Outcomes and Measures: The primary outcome was recurrence at last follow-up after single or multiple EA sessions. Secondary outcomes included receipt of subsequent surgery and the recurrence-free survival (RFS) rate after initial EA. Factors possibly associated with outcomes included patient age and sex; ranula site, type, diameter, volume, and echogenicity; the presentation-to-EA interval; parapharyngeal space extension; and sublingual gland herniation. Risk factors were identified on logistic regression analyses. Two-year RFS rates were analyzed for the initial cohort using the Kaplan-Meier method and compared by log-rank tests., Results: A total of 57 patients (mean [SD] age, 26.4 [12.1] years; 24 female individuals [42%]) who were followed up for a median of 57 months (range, 24-167 months) were included. The recurrence rate was 33% (n = 19), and 11 (19%) underwent subsequent surgery. Among patients with recurrence, 86% (31 of 36) experienced first recurrence within 12 months after initial EA. A presentation-to-EA interval of 12 months or longer was associated with an increased risk of recurrence (adjusted odds ratio [OR], 3.74; 95% CI, 1.01-13.82). No risk factors were significantly associated with subsequent surgery (highest OR in parapharyngeal space extension: adjusted OR, 4.96; 95% CI, 0.94-26.35). Among the initial cohort of 70 patients, 2-year RFS was lower in a maximum diameter of ranula of 5 cm or greater than less than 5 cm (24% [95% CI, 7%-41%] vs 50% [95% CI, 34%-66%]; difference, 26% [95% CI, -4% to 56%]; log-rank test, P = .02)., Conclusions and Relevance: This case-series study found that the recurrence rate of ranula after EA was 33%. A presentation-to-EA interval of 12 months or longer may be a risk factor for recurrence, suggesting that early intervention with EA might minimize recurrence. Most first recurrences occurred within 12 months after EA, with a maximum diameter of ranula of 5 cm or greater being a possible risk factor.
- Published
- 2024
- Full Text
- View/download PDF
139. Incidentally found parotid gland lesion in 18 F-FDG PET/CT for staging evaluation of patients with hepatocellular carcinoma: remote possibility of metastatic tumor or second primary salivary gland malignancy.
- Author
-
Jung JH, Lee YS, Jung YH, Choi SH, Nam SY, Cho HJ, and Kwon M
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Aged, Adult, Neoplasm Staging, Salivary Gland Neoplasms pathology, Salivary Gland Neoplasms diagnostic imaging, Incidence, Positron Emission Tomography Computed Tomography methods, Fluorodeoxyglucose F18, Liver Neoplasms diagnostic imaging, Liver Neoplasms pathology, Liver Neoplasms diagnosis, Liver Neoplasms epidemiology, Liver Neoplasms secondary, Carcinoma, Hepatocellular diagnostic imaging, Carcinoma, Hepatocellular pathology, Carcinoma, Hepatocellular diagnosis, Incidental Findings, Parotid Neoplasms diagnostic imaging, Parotid Neoplasms pathology, Parotid Neoplasms diagnosis, Radiopharmaceuticals, Neoplasms, Second Primary diagnostic imaging, Neoplasms, Second Primary pathology, Neoplasms, Second Primary epidemiology, Neoplasms, Second Primary diagnosis
- Abstract
Objectives: We primarily aimed to evaluate whether parotid incidental lesion (PIL) in
18 F-fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) for staging evaluation of patients with hepatocellular carcinoma (HCC) would represent a possibility of extrahepatic metastasis or second primary malignancy (SPM). Additionally, we explored the incidence of PIL in HCC patients and examined any associated risk factors., Methods: We retrospectively analyzed patients with HCC who underwent18 F-FDG PET/CT at our institution from 2010 to 2022. The pathological findings of PILs in HCC patients were investigated for confirmatory identification of the risk of HCC metastasis or SPM in parotid gland. Healthy controls received18 F-FDG PET/CT for health screening were also enrolled to compare the incidence of PILs with HCC patients. Various parameters associated with patient demographics and characteristics of HCC were analyzed to find the related factors of PILs., Results: A total of 17,674 patients with HCC and 2,090 healthy individuals who had undergone18 F-FDG PET/CT scans were enrolled in the analyses. Among the 54 HCC patients who underwent pathological confirmation for PILs, benign primary parotid tumor was most commonly observed (n = 43 [79.6%]); however, no malignant lesions were detected, including HCC metastasis. The incidence of PILs was higher in patients diagnosed with HCC compared with the control group (485 [2.7%] vs. 23 [1.1%], p = 0.002). Analysis for the risk factors for PILs revealed that patient age, sex, and positive viral markers were significantly associated with the incidence of PILs in patients with HCC (all p < 0.001)., Conclusions: Our study demonstrates that PILs are more frequently identified in patients with HCC on18 F-FDG PET/CT. However, no malignant PIL, including extrahepatic metastasis of HCC, was identified. Therefore, the presence of PIL should not impede or delay the treatment process for patients with HCC. Additionally, we suggested that for future swift and straightforward differential diagnoses of PIL, the development of additional protocols within the PET/CT imaging could be beneficial., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
140. Clinical implication of neck dissection for metastatic lymph nodes originating from non-head and neck regions.
- Author
-
Kim MJ, Kang SH, Kwon M, Jung YH, Choi SH, Nam SY, and Lee YS
- Subjects
- Humans, Female, Male, Retrospective Studies, Middle Aged, Aged, Case-Control Studies, Adult, Head and Neck Neoplasms pathology, Head and Neck Neoplasms surgery, Head and Neck Neoplasms mortality, Head and Neck Neoplasms secondary, Aged, 80 and over, Lymph Nodes pathology, Survival Rate, Neck Dissection, Lymphatic Metastasis pathology
- Abstract
Background: Cervical lymph node metastasis (CLNM) from remote primary sites is rare in head and neck cancer. The efficacy of neck dissection is still being investigated for therapeutic benefits of local management in oligometastasis from non-head and neck cancer., Objectives: To evaluate the clinical efficacy of neck dissection (ND) in CLNM from distant primary cancers and identify factors contributing to improved survival., Materials and Methods: This retrospective case-control study enrolled patients who underwent ND for CLNM from distant primary cancer at Asan Medical Centre between January 2010 and December 2020. We analysed overall survival and association between clinical covariate and survival., Results: The study included 31 (14 males, 17 females) among 114 patients. Ovarian cancer was the most common primary malignancy (32.3%). Patients with fewer than three metastatic lymph nodes, without extranodal extension and with adjuvant therapy after surgery had better survival rates., Conclusion and Significance: In patients with CLNM from a distant primary cancer, ND is beneficial as local treatment. And adequate selection of patients for ND is pivotal to improve prognosis.
- Published
- 2024
- Full Text
- View/download PDF
141. Predictive modelling for the diagnosis of oral and laryngeal premalignant and malignant lesions using p53 and Ki-67 expression.
- Author
-
Jeong JS, Cho KJ, Lee HJ, Roh J, Lee YS, and Song JS
- Subjects
- Humans, Ki-67 Antigen metabolism, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Hyperplasia, Precancerous Conditions diagnosis, Precancerous Conditions pathology, Carcinoma, Squamous Cell diagnosis
- Abstract
Oral and laryngeal epithelial lesions are currently diagnosed using histological criteria based on the World Health Organization (WHO) classification, which can cause interobserver variability. An integrated diagnostic approach based on immunohistochemistry (IHC) would aid in the interpretation of ambiguous histological findings of epithelial lesions. In the present study, IHC was used to evaluate the expression of p53 and Ki-67 in 114 cases of oral and laryngeal epithelial lesions in 104 patients. Logistic regression analysis and decision tree algorithm were employed to develop a scoring system and predictive model for differentiating the epithelial lesions. Cohen's kappa coefficient was used to evaluate interobserver variability, and next-generation sequencing (NGS) and IHC were used to compare TP53 mutation and p53 expression patterns. Two expression patterns for p53, namely, diffuse expression type (pattern HI) and null type (pattern LS), and the pattern HI for Ki-67 were significantly associated with high-grade dysplasia (HGD) or squamous cell carcinoma (SqCC). With an accuracy and area under the receiver operating characteristic curve (AUC) of 84.6% and 0.85, respectively, the scoring system based on p53 and Ki-67 expression patterns classified epithelial lesions into two types: non-dysplasia (ND) or low-grade dysplasia (LGD) and SqCC or HGD. The decision tree model constructed using the p53 and Ki-67 expression patterns classified epithelial lesions into ND, LGD, and group 2, including HGD or SqCC, with an accuracy and AUC of 75% and 0.87, respectively. The integrated diagnosis had a better correlation with near perfect agreement (weighted kappa 0.92, unweighted kappa 0.88). The patterns HI and LS for p53 were confirmed to be correlated with missense mutations and nonsense/frameshift mutations, respectively. A predictive model for diagnosis was developed based on the correlation between TP53 mutation and p53 expression patterns. These results indicate that the scoring system based on p53 and Ki-67 expression patterns can differentiate epithelial lesions, especially in cases when the morphological features are ambiguous., (Copyright © 2023 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
142. Letter-to-editor, "Feedback amplification of senolysis using caspase-cleavable peptide-doxorubicin conjugate and 2DG" [Journal of Controlled Release, Volume 346, pp. 158-168, (2022), doi: 10.1016/j.jconrel.2022.04.012].
- Author
-
Lee JC, Kim GC, Kim SW, Lee NK, Cho YS, Chung SW, Lee YS, Han MW, Chang HW, Byun Y, and Kim SY
- Published
- 2023
- Full Text
- View/download PDF
143. Concurrent Killian-Jamieson and Zenker's Diverticula.
- Author
-
Alotaibi FZ, Lee GD, and Lee YS
- Subjects
- Male, Humans, Adult, Zenker Diverticulum diagnostic imaging, Zenker Diverticulum surgery, Deglutition Disorders etiology, Diverticulum surgery, Physicians
- Abstract
Pharyngoesophageal diverticula are rare causes of dysphagia. Zenker's diverticulum is the most common type, followed by Killian-Jamieson diverticulum. A 44-year-old male presented to our clinic with a longstanding history of dysphagia and globus sensation. Bilateral pharyngoesophageal diverticula were confirmed by imaging CT and esophagogastroscopy. He underwent transcervical resection, and a right Killian-Jamieson diverticulum was observed during surgery. The left diverticulum was found to originate above the cricopharyngeus muscle and was labeled as Zenker's diverticulum. Bilateral pharyngoesophageal diverticula are rare, and physicians should be aware of the variable clinical presentations and management options for pharyngoesophageal diverticula., Competing Interests: No funds, grants, or other support were received, and there are no conflicts of interest to declare., (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Mutaz B. Habal, MD.)
- Published
- 2023
- Full Text
- View/download PDF
144. Surgical outcomes of 500 robot-assisted minimally invasive esophagectomies for esophageal carcinoma.
- Author
-
Jeon YH, Yun JK, Jeong YH, Gong CS, Lee YS, and Kim YH
- Abstract
Background: In 2003, robot-assisted minimally invasive esophagectomy (RAMIE) was first reported to overcome the technical limitations of minimally invasive esophagectomy. RAMIE requires repeated modifications to set up the robotic system, and sufficient experience is required to gain technical proficiency. This study aimed to identify the learning periods and the outcomes of RAMIE for esophageal carcinoma., Methods: We retrospectively reviewed 500 consecutive RAMIE cases for esophageal cancer from December 2008 to February 2021. The learning curve for RAMIE was identified using cumulative sum analysis., Results: In a total of 500 RAMIE patients, the Ivor Lewis and McKeown operation were performed in 267 patients (53.4%) and 192 patients (38.4%), respectively. We classified learning periods into the learning phase (first 50 cases), the developing phase (51-150 case), and the stable phase (151-500 case). The rates of vocal cord palsy (42.0% vs. 28.4%) and anastomotic leakage (10.0% vs. 6.4%) were reduced after the learning phase. The mean total operative time (420 vs. 373 min), the mean length of stay (21.6 vs. 16.7 days), and the rate of anastomotic stricture (27.0% vs. 12.4%) were significantly reduced after reaching stable phase. In the stable phase, the proportion of the Ivor Lewis operation (26.0% vs. 67.1%), neoadjuvant chemoradiation therapy (14.0% vs. 25.7%), and bilateral cervical node dissection cases (12.0% vs. 22.0%) were significantly increased., Conclusions: Fifty procedures might be needed to achieve early proficiency, and extensive experience of more than 150 procedures is needed for quality stabilization., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-637/coif). The authors have no conflicts of interest to declare., (2023 Journal of Thoracic Disease. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
145. Assessment of vocal fold movement through anterior-posterior view of videofluoroscopic swallowing study.
- Author
-
Lee J, Ahn HJ, Kang MS, Choi KH, Lee YS, Oh BM, and Lee SH
- Abstract
Objective: The aim of this study is to assess the value of using videofluoroscopic swallowing study (VFSS) for assessing vocal fold paralysis., Methods: This was a retrospective study of patients who underwent VFSS with a vocal fold testing maneuver from June 2020 to February 2022, and who had undergone laryngoscopy within 2 weeks before or after VFSS. The vocal fold testing maneuver consisted of making an 'e' sound for about 2-3 seconds during VFSS anterior-posterior (AP) view. The diagnostic value of the VFSS was evaluated by a trained reviewer, who assessed the presence and laterality of vocal fold paralysis by examining videos of the patients performing the vocal fold testing maneuver. Intra-rater reliability was determined by evaluation of the videos by the same reviewer 2 weeks later, and inter-rater reliability was determined by evaluation by a second reviewer., Results: Seventy patients were enrolled in the study. The positive predictive value was 91.43% and the intra-rater and inter-rater reliabilities, as determined by Cohen's kappa value, were 0.746 and 0.824 respectively., Conclusions: The presence and laterality of vocal fold paralysis were identified accurately and reliably by the reviewers, showing that VFSS can be used to assess vocal fold paralysis., Level of Evidence: 2., Competing Interests: No conflicts of interest have been reported by the authors of this article., (© 2023 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.)
- Published
- 2023
- Full Text
- View/download PDF
146. Clinical Practice Guidelines for Oropharyngeal Dysphagia.
- Author
-
Yang S, Park JW, Min K, Lee YS, Song YJ, Choi SH, Kim DY, Lee SH, Yang HS, Cha W, Kim JW, Oh BM, Seo HG, Kim MW, Woo HS, Park SJ, Jee S, Oh JS, Park KD, Jin YJ, Han S, Yoo D, Kim BH, Lee HH, Kim YH, Kang MG, Chung EJ, Kim BR, Kim TW, Ko EJ, Park YM, Park H, Kim MS, Seok J, Im S, Ko SH, Lim SH, Jung KW, Lee TH, Hong BY, Kim W, Shin WS, Lee YC, Park SJ, Lim J, Kim Y, Lee JH, Ahn KM, Paeng JY, Park J, Song YA, Seo KC, Ryu CH, Cho JK, Lee JH, and Choi KH
- Abstract
Objective: Dysphagia is a common clinical condition characterized by difficulty in swallowing. It is sub-classified into oropharyngeal dysphagia, which refers to problems in the mouth and pharynx, and esophageal dysphagia, which refers to problems in the esophageal body and esophagogastric junction. Dysphagia can have a significant negative impact one's physical health and quality of life as its severity increases. Therefore, proper assessment and management of dysphagia are critical for improving swallowing function and preventing complications. Thus a guideline was developed to provide evidence-based recommendations for assessment and management in patients with dysphagia., Methods: Nineteen key questions on dysphagia were developed. These questions dealt with various aspects of problems related to dysphagia, including assessment, management, and complications. A literature search for relevant articles was conducted using Pubmed, Embase, the Cochrane Library, and one domestic database of KoreaMed, until April 2021. The level of evidence and recommendation grade were established according to the Grading of Recommendation Assessment, Development and Evaluation methodology., Results: Early screening and assessment of videofluoroscopic swallowing were recommended for assessing the presence of dysphagia. Therapeutic methods, such as tongue and pharyngeal muscle strengthening exercises and neuromuscular electrical stimulation with swallowing therapy, were effective in improving swallowing function and quality of life in patients with dysphagia. Nutritional intervention and an oral care program were also recommended., Conclusion: This guideline presents recommendations for the assessment and management of patients with oropharyngeal dysphagia, including rehabilitative strategies.
- Published
- 2023
- Full Text
- View/download PDF
147. Swallowing analysis in hemi-tongue reconstruction using motor-innervated free flaps: A cine-magnetic resonance imaging study.
- Author
-
Kim YC, Lee SJ, Park H, Choi YJ, Jeong WS, Lee YS, Choi KH, Oh TS, and Choi JW
- Subjects
- Humans, Deglutition, Retrospective Studies, Tongue surgery, Glossectomy methods, Magnetic Resonance Imaging, Free Tissue Flaps, Tongue Neoplasms pathology
- Abstract
Background: This study aimed to explore the outcomes of motor-innervated free flaps in hemi-tongue reconstruction by assessing the tongue mobility through midsagittal images from cine-magnetic resonance imaging., Methods: In this retrospective study, 47 patients who underwent tongue reconstruction following hemi-glossectomy and 10 control subjects without any surgical history were included. Patients were classified into two groups: the motor and no-motor innervation group. Various spatial parameters related to tongue mobility that were acquired from midsagittal sections were compared during consecutive swallowing phases., Results: Overall, the motor group showed improved functional swallowing scale compared with the no-motor group. In case of tongue base resection, the motor group showed improved mobility of the tongue base during pharyngeal phase, whereas the no-motor group showed increased laryngeal elevation for compensatory movement., Conclusion: The tongue reconstruction with motor-innervated free flaps may facilitate swallowing capacity in patients with a hemi-tongue defect combined with tongue base resection., (© 2023 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
148. Frequent apocrine changes in pleomorphic adenoma with malignant transformation: a possible pre-malignant step in ductal carcinoma ex pleomorphic adenoma.
- Author
-
Song JS, Kim Y, Lee YS, Choi SH, Nam SY, Kim SY, and Cho KJ
- Abstract
Background: The most common type of carcinoma ex pleomorphic adenoma (CPA) is histologically equivalent to salivary duct carcinoma, which has an apocrine phenotype. Invasive CPA is often accompanied by non-invasive or in situ carcinoma, an observation that suggests the presence of precursor lesions. The aim of this study was to identify candidate precursor lesions of CPA within pleomorphic adenoma (PA)., Methods: Eleven resected cases of CPA with residual PA and 17 cases of PA with atypical changes were subjected to immunohistochemistry (IHC) for p53, human epidermal growth factor receptor 2 (HER2), androgen receptor (AR), pleomorphic adenoma gene 1, gross cystic disease fluid protein-15 (GCDFP-15), and anti-mitochondrial antibody., Results: Invasive or in situ carcinoma cells in all CPAs were positive for AR, GCDFP-15, and HER2. Atypical foci in PAs corresponded to either apocrine or oncocytic changes on the basis of their reactivity to AR, GCDFP-15, and anti-mitochondrial antibody. Atypical cells in PAs surrounding CPAs had an apocrine phenotype without HER2 expression., Conclusions: Our study identified frequent apocrine changes in residual PAs in CPA cases, suggesting a possible precursor role of apocrine changes. We recommend the use of HER2 IHC in atypical PAs, and that clinicians take HER2 positivity into serious consideration.
- Published
- 2023
- Full Text
- View/download PDF
149. Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer.
- Author
-
Kim H, Park HJ, Chang HW, Back JH, Lee SJ, Park YE, Kim EH, Hong Y, Kwak G, Kwon IC, Lee JE, Lee YS, Kim SY, Yang Y, and Kim SH
- Abstract
Highly immunosuppressive tumor microenvironment containing various protumoral immune cells accelerates malignant transformation and treatment resistance. In particular, tumor-associated macrophages (TAMs), as the predominant infiltrated immune cells in a tumor, play a pivotal role in regulating the immunosuppressive tumor microenvironment. As a potential therapeutic strategy to counteract TAMs, here we explore an exosome-guided in situ direct reprogramming of tumor-supportive M2-polarized TAMs into tumor-attacking M1-type macrophages. Exosomes derived from M1-type macrophages (M1-Exo) promote a phenotypic switch from anti-inflammatory M2-like TAMs toward pro-inflammatory M1-type macrophages with high conversion efficiency. Reprogrammed M1 macrophages possessing protein-expression profiles similar to those of classically activated M1 macrophages display significantly increased phagocytic function and robust cross-presentation ability, potentiating antitumor immunity surrounding the tumor. Strikingly, these M1-Exo also lead to the conversion of human patient-derived TAMs into M1-like macrophages that highly express MHC class II, offering the clinical potential of autologous and allogeneic exosome-guided direct TAM reprogramming for arming macrophages to join the fight against cancer., Competing Interests: The authors declare no conflicts of interest., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
150. Surgical outcomes of oro-intestinal continuity reconstruction after total esophagectomy in patients with cervicothoracic malignancy: a thoracic surgeon's perspective.
- Author
-
Kim D, Yun JK, Lee YS, Kim EK, Kim CW, and Kim YH
- Abstract
Background: Oro-intestinal continuity reconstruction following total esophagectomy in patients with head-neck or esophageal cancer is rare and results in high operative morbidity and mortality. This case series aimed to investigate the perioperative surgical outcomes of oro-intestinal continuity reconstruction after total esophagectomy in selected patients with advanced head/neck or esophageal cancer., Methods: From 2011 to 2018, 14 patients who underwent oro-intestinal reconstruction after total esophagectomy were assessed. We analyzed perioperative mortality, postoperative complications, oncologic outcomes, and recovery of dietary function., Results: The median age of the patients was 61 (range, 42-72) years old and median follow-up time was 18.6 (range, 0-52.9) months. For conduit selection, 11 cases of oro-gastrostomy (78.6%), 2 of oro-colo-gastrostomy (14.3%), and 1 of oro-jejuno-gastrostomy (7.1%) were performed. Complete resection was pathologically confirmed in 10 patients (71.4%). Anastomosis site leakage was observed in three patients (21.4%) and conduit necrosis in two (14.3%). Postoperative mortality within 30 days, 90 days, and 1 year was 7.1%, 28.6%, and 42.8%, respectively., Conclusions: Oro-intestinal continuity reconstruction following total esophagectomy showed acceptable morbidity and mortality in selected patients with advanced head/neck cancer or esophageal cancer. Careful selection of surgical candidates and multidisciplinary collaboration of experienced surgical teams are essential to minimize the surgical risk., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-21-1768/coif). The authors have no conflicts of interest to declare., (2022 Journal of Thoracic Disease. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.